Notable Friday Option Activity: HARP, ZUMZ, IRBT Friday, June 4, 5:45 PM ET, by Market News Video Staff Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...
Relative Strength Alert For Harpoon Therapeutics Monday, June 7, 12:03 PM ET, by Market News Video Staff Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Harpoon Therapeutics is Now Oversold (HARP) Monday, June 28, 4:23 PM ET, by Market News Video Staff Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Implied XBI Analyst Target Price: $215 Monday, July 12, 8:15 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
HARP Makes Notable Cross Below Critical Moving Average
By Market News Video Staff, Friday, June 4, 11:53 AM ET
In trading on Friday, shares of Harpoon Therapeutics Inc (NASDAQ:HARP) crossed below their 200 day moving average of $17.94, changing hands as low as $15.50 per share. Harpoon Therapeutics Inc shares are currently trading off about 24.4% on the day. The chart below shows the one year performance of HARP shares, versus its 200 day moving average:
Looking at the chart above, HARP's low point in its 52 week range is $10.55 per share, with $25.235 as the 52 week high point — that compares with a last trade of $15.83.
This Article's Word Cloud:AverageBelowClickCrossingFridayHARPHarpoonLookingMovingStartStocksTheirTherapeuticsaboutaboveaveragebecomebelowbrainchangingchartcomparescrossedcurrentlyfindhandsherehighlastmdashmovingperformancepointpredictingrangeraquosharesharesshowsslideshowthattheirtradetradingtrainedversusweekwithwizardyear
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.